New York City GranuFlo and Naturalyte Defective Drug Lawyers

FDA Issues Class I Recall of GranuFlo and Naturalyte

On March 29, 2012 the FDA issued a Class I recall of Naturalyte and Granuflo Acid Concentrate dialysis products manufactured by Fresenius Medical Care. As part of the recall, the FDA now believes there is a reasonable probability that use of GranuFlo and Naturalyte products will lead to severe adverse health consequences and may even lead to death.

Additionally, there has been a general safety communication issued by the FDA regarding the inappropriate prescriptions of GranuFlo and Naturalyte. These prescriptions have resulted in large alkali dosing errors in GranuFlo and Naturalyte.

What Is GranuFlo and Naturalyte?

GranuFlo and Naturalyte are products manufactured by Fresenius Medical Care. Fresenius Medical Care is responsible for the treatment of nearly 150,000 Americans who receive dialysis. Fresenius is also a leading supplier of disposable products and dialysis machines in the United States.

Specifically, GranuFlo and Naturalyte are drugs used during dialysis that are designed to help maintain the appropriate balance of acidity to alkalinity in the bloodstream of patients. GranuFlo is one of the most-widely prescribed dry acid dialysis products in the industry.

What Are the Side-Effects of GranuFlo and Naturalyte?

The use of GranuFlo and Naturalyte has been shown to cause a high serum bicarbonate level in hemodialysis patients. High bicarbonate levels can substantially increase risks for the following:

Cardiac arrest
Low blood pressure
Cardiac arrhythmia
Low blood oxygen pressure
Low potassium levels in the blood
High concentration of carbon dioxide in the blood
Metabolic alkalosis

Cardiopulmonary Arrest caused by GranuFlo and Naturalyte

After nearly 1,000 cases of cardiac arrest linked to GranuFlo and Naturalyte were reported to the manufacture, Fresenius, an investigation was conducted to determine the correlation between the drug and patient related incidents. According to an internal memo released by Fresenius Medical Care in November 4, 2011, the investigation found that there were 941 instances of cardiopulmonary arrest at 667 different Fresenius facilities between January 1, 2010 and December 31, 2010.

Legal Help for GranuFlo and Naturalyte Drug Injury Victims

If you believe that you suffer from injuries as a result of the use of the drug GranuFlo or Naturalyte, contact the New York City defective drug law firm at Finz & Finz, P.C., now toll free at (855) TOP-FIRM or simply complete the Free GranuFlo/Naturalyte Drug Injury Case Evaluation form to find out how Finz & Finz, P.C., can help you.

Recent Defective Drug Blog Articles

Product Liability and Consumer Safety August 18, 2020 | Leonard L. Finz
The True Tale: Americans buy products by the millions. All are intended for safe and effective use. But are they? Most are, but what about those that bring harm right to the consumer’s front door? Example; A motorized lawnmower that jams up and ultimately slices a hand due to a cheap
Continue Reading
FDA Targets Dangerous Contraceptive Device August 20, 2018 | Finz & Finz, P.C.
The Food and Drug Administration (FDA) has cracked down on Bayer’s controversial birth control device, Essure, after repeated reports of the device migrating or causing other significant side effects. Though the FDA initially approved the device in 2002, the government agency is now requiring Bayer to conduct further safety tests.
Continue Reading
Pharmaceutical Companies Continue to Market Dangerous Drugs March 30, 2018 | Finz & Finz, P.C.
Every once in a while, a pharmaceutical company will release a drug dangerous enough to draw national attention. Whether it be Zoloft causing significant birth defects, Paxil being associated with suicidal ideation, or Ambien causing people to do dangerous things in their sleep, these cases temporarily remind the American public
Continue Reading

View All Defective Drug Blog Articles